SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is facing intense downward pressure driven by concerns over high capital expenditures and a credit rating downgrade, keeping the stock near multi-year lows despite a massive, multi-billion dollar contracted backlog. The community remains deeply divided, with bears pointing to ballooning debt and execution risks, while bulls maintain high conviction, viewing the pullback as a temporary disconnect between the company's long-term AI infrastructure potential and the current market narrative.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is seeing heightened activity following its annual meeting, where shareholders voted to increase the company's authorized share count to support a potential acquisition of eBay. While some in the community express frustration over long-term volatility and dilution concerns, bullish sentiment persists among others who view the move as a strategic step toward transforming the company into a holding entity.

Q32 Bio, Inc. operates as a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. It focuses on the IL-7 / TSLP receptor pathways and complement system, addressing immune dysregulation to help patients take back control of their lives. The company was founded by David Grayzel and Shelia Violette in 2017 and is headquartered in Waltham, MA.

Q32 Bio Inc.

Q32 Bio is trending following the sale of its complement inhibitor ADX-097 to Akebia Therapeutics, a catalyst that has sparked debate over the stock's valuation relative to its cash position and future pipeline potential. Community members are actively discussing the likelihood of a short squeeze, the impact of potential dilution, and whether the current price action signals a long-term turnaround or a temporary momentum play.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is trending as investors rotate into enterprise software, viewing the stock as a critical platform for enterprise-wide AI agent adoption and workflow automation. The community is actively debating its long-term potential as a 'sticky' industry leader, with significant attention on upcoming earnings and bullish technical setups.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin (APP) is experiencing significant market volatility, driven by investor reactions to recent e-commerce ad pixel adoption data and ongoing debates regarding its long-term growth sustainability. While some market participants express skepticism about the stock's valuation and the competitive landscape, others continue to emphasize its strong fundamentals and AI-driven ad monetization, leading to active community discussion over whether the current pullback represents a buying opportunity or a deeper structural concern.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Menlo Park, CA.

Snowflake Inc

Snowflake Inc. (SNOW) is experiencing a period of intense trading volume and volatility as investors react to its latest earnings report, which highlighted significant enterprise cloud demand and AI-driven data platform growth. The community is actively discussing the stock's impressive relative strength, with many debating whether recent price surges represent a sustainable breakout or a classic short squeeze.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending as investors debate the company's shift toward agentic AI orchestration, with the community split between bulls betting on a short squeeze due to high short interest and skeptics concerned by persistent price stagnation. Despite the price action, supporters highlight the companys GAAP profitability, cash-rich balance sheet, and ongoing share buybacks as fundamental reasons for long-term optimism.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is facing intense selling pressure as broader market volatility and a rotation out of speculative growth sectors weigh on quantum computing stocks. While investors remain focused on long-term government tailwinds and potential commercial scaling, community sentiment is currently divided between those bracing for further downside toward historical support levels and long-term believers advocating for accumulation during this pullback.

Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.

Personalis Inc

Personalis is currently experiencing significant market momentum and high volatility, driven by community anticipation of a potential short squeeze alongside ongoing institutional buying and speculation about a future acquisition. Investors are closely monitoring the company's test volume growth and upcoming clinical trial milestones, debating whether current price action is justified by its long-term potential in the precision oncology market.

REalloys, Inc. is engaged in the rebuilding of domestic supply chain resilience for rare earth elements and magnets. It is involved in recycling, mining, oxide production, metallization, alloying, and magnet manufacturing. The company was founded on October 4, 2011 and is headquartered in Boca Raton, FL.

REalloys Inc.

REalloys Inc. is trending as investors react to the company's recent formal inclusion in the Russell 3000 Index and bullish analyst coverage targeting a price point of $19. Community discussion is heavily focused on the company's strategic partnerships for U.S.-based rare earth processing and its pivotal role in decoupling the domestic supply chain from China ahead of regulatory deadlines.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SLS Vs MLTX: Retail Traders Race To Pick Merck’s Next Biotech Buyout As Keytruda’s $31.7B Patent Cliff Nears

Equity

SLS leads in stock momentum, while MLTX is cheaper and better-funded, with nearly $300 million in cash at the end of the first quarter.

Nasdaq, S&P 500, Dow Futures Fall After Trump Directs Strikes ‘To Hold Iranian Forces Accountable’: NVDA, SLS, MRK, SKHYV, QS Stocks In Focus

U.S. Central Command said that American forces had begun launching further strikes against Iran to thwart their ability “to attack civilian mariners and commercial ships freely transiting the Strait of Hormuz.”

SLS Stock Snaps 2-Day Slide: Sellas’ SLS009 AML Trial Spotlights Big Pharma Drug Combo From ABBV, RHHBY And BMY

SLS009 traces back to Sellas’ 2022 GenFleet licensing deal, when the company obtained rights outside Greater China to GFH009, now known as SLS009.

SLS Stock In The Spotlight As CEO Pushes Back On Regal Trial Criticism – ‘Let’s Separate The Noise From The Data’ 

 CEO Angelos M. Stergiou addressed concerns over the company’s trial to treat acute myeloid leukemia.

SELLAS Life Sciences Shares Slip Wednesday as Price Tests $16 Resistance Wall

SELLAS Life Sciences Group shares are trading lower Wednesday as investors take profits, with risk appetite softer across equities.read more...

SLS Stock Logs 2-Day Losing Streak: Mixed Institutional Bets Emerge Ahead Of Key AML Trial Update 

Gamma Investing cut its SLS stake by 259 shares, or 32%, holding 556 shares worth about $8,210 as of June 30.

SLS Stock Rises Overnight: Why Retail Traders Prefer Sellas Over IBRX, ONDS, PYPL As Most Bullish Pick

Traders are watching for the 80th event, data lock and topline results, while some are also speculating about potential M&A.

SLS Stock Notches 3-Week Winning Run: MassMutual Opens Tiny Stake Ahead Of Key AML Readout 

First Financial Bank also held 10,000 SLS shares, valued at $147,600.

Nasdaq, S&P 500, Dow Futures Rise After Fourth Of July Break As Investors Await Fed Minutes: SLS, ONDS, HOOD, MARA, HUT In Focus

U.S. stock futures edged higher in the overnight session ahead of Monday’s open following a strong rally in the prior week. 

SLS Stock Sees Worst Day In Over A Month — But Prediction Market Flashes 83% Odds For November AML Trial Success 

Endpoint Area listed Nov. 30 as the expected catalyst timing for Sellas’ Phase 3 GPS trial.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Bullish Sentiment

$TMDX

$SLS

Which of these trending stocks are you most tempted to buy - $ON, $TMDX, $SLS, or $BE?

Stocktwits

ON Semiconductor Corp.

Transmedics Group Inc

Bloom Energy Corp - Ordinary Shares - Class A

Which of these trending stocks are you most tempted to buy - 

Stocktwits Polls

Massive, unusual call option volume suggests institutional whales are positioning for an imminent breakthrough.

Investors are on high alert for the 80th clinical event, seen as the primary trigger for data readout and share price movement.

Fervent speculation about a major pharma acquisition persists as traders monitor Merck for potential deals.

Longs anticipate an unhedged liquidation event as structural bottlenecks intensify the pressure on current short positions.

Feed

News

Sentiment

Earnings

Fundamentals

Info

SLSSELLAS Life Sciences Group Inc

Latest SLS News